文献速递临床试验与 GCP

地塞米松作为镇痛辅助药用于全膝关节置换术后多模式疼痛治疗的效果:随机临床试验

Effect of dexamethasone as an analgesic adjuvant to multimodal pain treatment after total knee arthroplasty: randomised clinical trial.
PubMed 文献 · BMJ · 2022-01-04

在丹麦五家医院进行的随机、盲法、安慰剂对照试验纳入485例全膝关节置换术成人患者,比较单剂地塞米松、两剂地塞米松与安慰剂对术后48小时静脉吗啡消耗量的影响。两剂地塞米松组较安慰剂组显著减少吗啡消耗并减轻术后疼痛,单剂组与安慰剂组差异未达预设显著性阈值。

要点

  • 单剂与两剂地塞米松之间吗啡消耗差异无统计学显著(P=0.30)。

核心结论

  • 两剂地塞米松减少全膝关节置换术后48小时内的吗啡消耗并减轻术后疼痛。

研究设计与样本

  • 随机、盲法、安慰剂对照试验,随访90天,在丹麦五家医院于2018年9月至2020年3月进行。
  • 纳入485例接受全膝关节置换术的成人参与者,随机分为DX1组161例、DX2组162例和安慰剂组162例。
  • 干预于术前和术后24小时给予:DX1为地塞米松24 mg+安慰剂,DX2为地塞米松24 mg+地塞米松24 mg,安慰剂组为安慰剂+安慰剂。
  • 所有参与者均接受对乙酰氨基酚、布洛芬和局部浸润镇痛。
  • 主要结局分析纳入472例参与者(97.3%)的数据。

主要发现

  • 术后0至48小时吗啡消耗中位数(四分位距):DX1组37.9 mg(20.7至56.7),DX2组35.0 mg(20.6至52.0),安慰剂组43.0 mg(28.7至64.0)。
  • DX1与DX2组间Hodges-Lehmann中位差为-2.7 mg(98.3%CI -9.3至3.7),P=0.30。
  • 单剂地塞米松在24小时减轻术后疼痛,两剂地塞米松在48小时减轻术后疼痛。

关键数值与推荐

  • 主要结局为术后0至48小时静脉吗啡总消耗量。
  • 多重比较校正后的统计学显著性阈值为P<0.017,最小重要差异为10 mg吗啡。

局限性

  • 原文未报告局限性。

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

原文

OBJECTIVE: To investigate the effects of one and two doses of intravenous dexamethasone in patients after total knee arthroplasty. DESIGN: Randomised, blinded, placebo controlled trial with follow-up at 90 days. SETTING: Five Danish hospitals, September 2018 to March 2020. PARTICIPANTS: 485 adult participants undergoing total knee arthroplasty. INTERVENTION: A computer generated randomised sequence stratified for site was used to allocate participants to one of three groups: DX1 (dexamethasone (24 mg)+placebo); DX2 (dexamethasone (24 mg)+dexamethasone (24 mg)); or placebo (placebo+placebo). The intervention was given preoperatively and after 24 hours. Participants, investigators, and outcome assessors were blinded. All participants received paracetamol, ibuprofen, and local infiltration analgesia. MAIN OUTCOME MEASURES: The primary outcome was total intravenous morphine consumption 0 to 48 hours postoperatively. Multiplicity adjusted threshold for statistical significance was P<0.017 and minimal important difference was 10 mg morphine. Secondary outcomes included postoperative pain. RESULTS: 485 participants were randomised: 161 to DX1, 162 to DX2, and 162 to placebo. Data from 472 participants (97.3%) were included in the primary outcome analysis. The median (interquartile range) morphine consumptions at 0-48 hours were: DX1 37.9 mg (20.7 to 56.7); DX2 35.0 mg (20.6 to 52.0); and placebo 43.0 mg (28.7 to 64.0). Hodges-Lehmann median differences between groups were: -2.7 mg (98.3% confidence interval -9.3 to 3.7), P=0.30 between DX1 and DX2; 7.8 mg (0.7 to 14.7), P=0.008 between DX1 and placebo; and 10.7 mg (4.0 to 17.3), P<0.001 between DX2 and placebo. Postoperative pain was reduced at 24 hours with one dose, and at 48 hours with two doses, of dexamethasone. CONCLUSION: Two doses of dexamethasone reduced morphine consumption during 48 hours after total knee arthroplasty and reduced postoperative pain. TRIAL REGISTRATION: Clinicaltrials.gov NCT03506789.

来源:BMJ,查看原文。版权归原作者所有。

引用

  1. Gasbjerg KS, Hägi-Pedersen D, Lunn TH, et al. Effect of dexamethasone as an analgesic adjuvant to multimodal pain treatment after total knee arthroplasty: randomised clinical trial. BMJ. 2022. PMID: 34983775. doi:10.1136/bmj-2021-067325

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。